Amarin Corp Plc (AMRN)

[sts66]

Which is exactly why this "share the vaccine IP" stuff is going nowhere - it changes nothing - the bottleneck is still access to sufficient raw materials (our API) - allowing other countries to make mRNA vaccines will just result in more companies fighting over limited supplies and could actually cause a DECREASE in available vaccines. Plus you don't just hand over a recipe and other countries can start producing (same as DRL not being able to source API), it takes specialized facilities and specialized workers - if they don't exist now you can't build them overnight.